GLPBio

8pyDTZ

Catalog No.: GC39334Purity:>98.00%
8pyDTZ is a pyridyl diphenylterazine (DTZ) analog designed for bioluminescent imaging, specifically optimized for use with the LumiLuc luciferase system.

Products are for research use only. Not for human use. We do not sell to patients.


8pyDTZ
Cas No.: 2351898-91-2
1mgIn Stock
$184.00
1
5mgIn Stock
$405.00
1

Citations

No citations are currently available for this product. Below are selected publications citing GlpBio products.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

Description

8pyDTZ is a pyridyl diphenylterazine (DTZ) analog designed for bioluminescent imaging, specifically optimized for use with the LumiLuc luciferase system. In the presence of pyridyl substrates 8pyDTZ, LumiLuc generates highly bright yellow bioluminescence. 8pyDTZ offers enhanced water solubility and red-shifted emission, making it suitable for in vivo imaging applications[1]. 8pyDTZ has about 13 times better aqueous solubility and bioavailability than DTZ. The emission from 8-pyDTZ/LumiLuc was about 5 times brighter than 8-pyDTZ/teLuc[2].

In vitro, the 8pyDTZ (30µM) can been used to quantify biomarkers such as human serum albumin (HSA) in serum samples and α-amylase in saliva samples by incubating the analyte of interest for 30min at 25℃[3].

In vivo, 8pyDTZ (0.2μmol/mouse) in 100μL normal saline is administrated into luciferase expressing HeLa cells xenograft mouse model via intravenous delivery to track tumor growth with high sensitivity and good tissue penetration ability[1].

References:
[1] Yeh H W, Xiong Y, Wu T C, et al. ATP-Independent Bioluminescent Reporter Variants To Improve in Vivo Imaging. ACS Chem Biol. 2019 May 17;14(5):959-965.
[2] Syed A J, Anderson J C. Applications of bioluminescence in biotechnology and beyond. Chem Soc Rev. 2021 May 7;50(9):5668-5705.
[3] Guo Z, Parakra R D, Xiong Y, et al. Engineering and exploiting synthetic allostery of NanoLuc luciferase. Nat Commun. 2022 Feb 10;13(1):789.

Protocol

The use of 8pyDTZ in HEK 293T cells to evaluate its bioluminescence performance:
1. Culture HEK 293T cells in DMEM with 10% FBS at 37°C with 5% CO2.
2. Perfom transfection when cell confluency reaches 70-80%.
3. Transiently transfect cells with the LumiLuc luciferase expression plasmid using liposome-based transfection
4. The expression of LumiLuc luciferase in the cells was detected 24-48 hours after transfection.
5. Dissolve 8pyDTZ in ethanol to a concentration of 10mM.
6. Use an assay buffer composed of 1mM CDTA, 0.5% Tergitol NP-40, 0.05% Antifoam 204, 150mM KCl, 100mM MES pH 6.0, 1mM DTT, and 35mM thiourea.
7. Dilute the 8pyDTZ stock solution (10mM) in the assay buffer to final concentration of 20µM.
8. Seed transfected cells into 96-well plate at a density of 5,000 cells/well.
9. Allow cells to adhere and recover for 2-4 hours in the incubator.
10. Add 50µL of the 8pyDTZ (20µM) containing solution to each well containing the transfected cells.
11. Incubate the cells with 8pyDTZ at 37°C for 10 minutes.
12. Perform bioluminescence imaging immediately after incubation using a luminescence plate reader with exposure time of 2s.
13. Use a 600-700nm bandpass filter to capture far-red emission.
This protocol only provides a guideline, and should be modified according to your specific needs.

References:
[1] Yeh H W, Xiong Y, Wu T C, et al. ATP-Independent Bioluminescent Reporter Variants To Improve in Vivo Imaging. ACS Chem Biol. 2019 May 17;14(5):959-965.

Product Documents

Purity:>98.00%Appearance:A solid

Chemical Properties

CAS No.
2351898-91-2
SMILES
O=C1C(CC2=CC=CC=C2)=NC3=C(C4=CC=NC=C4)NC(C5=CC=CC=C5)=CN31
Molecular Formula
C24H18N4O
Molecular Weight
378.43
Solubility
DMSO: 12.5 mg/mL (33.03 mM; DMSO can inactivate 8pyDTZ's activity); EtOH+HCl: 2 mg/mL (5.28 mM; ultrasonic and adjust pH to 2 with 1M HCl; DMSO can inactivate 8pyDTZ's activity); Water: < 0.1 mg/mL (insoluble; DMSO can inactivate 8pyDTZ's activity)
Storage
Store at -20°C,unstable in solution, ready to use.
General tips
Select a suitable solvent according to the product solubility data. Once prepared, aliquot the stock solution to avoid repeated freeze-thaw cycles.
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
Shipping Condition
Evaluation samples are shipped with blue ice. Other available sizes are shipped at room temperature or with blue ice upon request.

CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility

g/mol

Reviews

Review for 8pyDTZ

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%